MY8700562A - Pyrimidones - Google Patents

Pyrimidones

Info

Publication number
MY8700562A
MY8700562A MY562/87A MY8700562A MY8700562A MY 8700562 A MY8700562 A MY 8700562A MY 562/87 A MY562/87 A MY 562/87A MY 8700562 A MY8700562 A MY 8700562A MY 8700562 A MY8700562 A MY 8700562A
Authority
MY
Malaysia
Prior art keywords
pyrimidones
Prior art date
Application number
MY562/87A
Other languages
English (en)
Inventor
Joachim Heider
Volkhard Austel
Wolfgang Eberlein
Rudolf Kadatz
Christian Lillie
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of MY8700562A publication Critical patent/MY8700562A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MY562/87A 1980-12-12 1987-12-30 Pyrimidones MY8700562A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MY8700562A true MY8700562A (en) 1987-12-31

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
MY562/87A MY8700562A (en) 1980-12-12 1987-12-30 Pyrimidones

Country Status (22)

Country Link
US (1) US4379788A (https=)
EP (1) EP0054132B1 (https=)
AR (1) AR227567A1 (https=)
AU (1) AU543568B2 (https=)
CA (1) CA1217767A (https=)
CS (1) CS227024B2 (https=)
DD (1) DD208151A5 (https=)
DE (1) DE3166627D1 (https=)
DK (1) DK525481A (https=)
ES (2) ES8207156A1 (https=)
FI (1) FI813971A7 (https=)
GB (1) GB2090249B (https=)
GR (1) GR76952B (https=)
HU (1) HU187384B (https=)
IL (1) IL64504A (https=)
MY (1) MY8700562A (https=)
NO (1) NO814239L (https=)
NZ (1) NZ199254A (https=)
PH (1) PH18930A (https=)
PL (1) PL135330B1 (https=)
PT (1) PT74116B (https=)
SU (1) SU1056900A3 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
CA2395558C (en) * 1997-11-12 2007-07-17 Bayer Aktiengesellschaft Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
RU2207337C2 (ru) * 1998-11-18 2003-06-27 Изаксон Елена Александровна 6-(3-ацетилфенил)аминоурацил
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
CN1518447A (zh) * 2001-04-23 2004-08-04 �������Ǵ�ѧר������� 作为抗血管生成剂的新的苯邻二甲酰亚胺模拟物的合成和评估
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
CA2549641A1 (en) * 2003-12-19 2005-07-21 Merck & Co., Inc. Mitotic kinesin inhibitors
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
JPWO2005115993A1 (ja) * 2004-05-31 2008-03-27 萬有製薬株式会社 キナゾリン誘導体
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のpde阻害剤およびそれらの組合せ
EP2079739A2 (en) * 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CN102098918A (zh) * 2008-05-13 2011-06-15 帕纳德制药公司 用于治疗癌症和神经退行性疾病的生物活性化合物
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
RU2650107C2 (ru) 2012-09-26 2018-04-09 Мерк Патент Гмбх Производные хиназолинона в качестве ингибиторов parp

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
PH18930A (en) 1985-11-11
CS227024B2 (en) 1984-04-16
PT74116A (de) 1982-01-01
US4379788A (en) 1983-04-12
DE3166627D1 (en) 1984-11-15
ES507761A0 (es) 1982-09-01
AU543568B2 (en) 1985-04-26
GB2090249B (en) 1984-08-22
DD208151A5 (de) 1984-03-28
EP0054132B1 (de) 1984-10-10
PL234175A1 (https=) 1982-08-16
NZ199254A (en) 1985-02-28
SU1056900A3 (ru) 1983-11-23
HU187384B (en) 1985-12-28
DK525481A (da) 1982-06-13
FI813971L (fi) 1982-06-13
GR76952B (https=) 1984-09-04
AR227567A1 (es) 1982-11-15
PL135330B1 (en) 1985-10-31
ES8304096A1 (es) 1983-02-16
AU7847381A (en) 1982-06-17
IL64504A0 (en) 1982-03-31
FI813971A7 (fi) 1982-06-13
ES8207156A1 (es) 1982-09-01
IL64504A (en) 1985-02-28
NO814239L (no) 1982-06-14
EP0054132A1 (de) 1982-06-23
PT74116B (de) 1983-12-19
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
CA1217767A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
MY8700562A (en) Pyrimidones
CS339581A2 (en) Zpusob vyroby novych oxiranu
GB2088869B (en) 8-arylalkyl-3-phenyl-3-nortropanols
IL62920A (en) Carry-bag
JPS57128695A (en) Phenoxyalkoxysilanes
GB2076402B (en) 2-nitroimidazoles
GB2071518B (en) Elutriators
GB2076397B (en) 2-guanidinothiazoles
CS693481A2 (en) Zpusob koksovani smesi vysokovroucich aromatickych uhlovodiku
CS90981A2 (en) Zpusob vyroby beta-laktamu
GB2080308B (en) 11-amino-androstane-17-carboxylates
JPS57122098A (en) 19-alpha-dehalogenation
JPS5710146A (en) Photocomposer
JPS5783480A (en) Non-tapping type bar-code-printer
CS227481A2 (en) Zpusob pripravy vincristinu
JPS56121536A (en) Hemadinamometer
JPS56156269A (en) Triazole-benzyloxy-ketone and-carbinol
JPS56116225A (en) Pushhbutton member
CS436281A1 (en) Skelet jizdniho ergometru
JPS5767500A (en) Scissors-lift
JPS56145254A (en) 2-haloacetanilides
GB2075973B (en) Indoloquinolizines
NZ196619A (en) Turnbuckle-telescopic type
CS941880A2 (en) Praci stroj
CS870181A1 (en) Nosnik stozaru trifazoveho elektrickeho vedeni